Skip to main
IEX

IDEX (IEX) Stock Forecast & Price Target

IDEX (IEX) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

IDEX is a strong investment opportunity with a focus on sustainable growth through its integrated strategy and positive long-term book-to-bill ratio, particularly in the growing life sciences industry. The company's recent joint venture and potential for acquisitions demonstrate its commitment to capital deployment and future growth. However, there may be potential risks related to the company's reliance on AI adoption and datacenter capex. Overall, IDEX offers a high-margin business, favorable market trends, and strong financial performance, making it a top pick for investors.

Bears say

IDEX is facing risks from a mixed short-cycle business environment and potential macro uncertainties in its growth platforms, which could hinder its cash EPS and result in a scenario where shares trade at a 20% discount to peers, valuing it at $160. An additional risk lies in the company's short replenishment cycle, which could limit its visibility for the quarter and the year. Furthermore, portfolio rationalization efforts through the 80/20 strategy could lead to the premature exit of businesses, potentially hindering long-term growth opportunities. Overall, these factors contribute to a negative outlook on IDEX's stock in the near term.

IDEX (IEX) has been analyzed by 8 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IDEX and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IDEX (IEX) Forecast

Analysts have given IDEX (IEX) a Buy based on their latest research and market trends.

According to 8 analysts, IDEX (IEX) has a Buy consensus rating as of Aug 1, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $250.12, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $250.12, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IDEX (IEX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.